Goal
To treat skin cancer and other skin disorders using a topical bloodroot extract.
Problem
Skin cancer (basal cell carcinoma, cervical cancer cells), oral leukitis, periodontal disease, and certain bacterial infections.
Concept Summary
Bloodroot (Sanguinaria canadensis) rhizome extracts contain the alkaloid sanguinarine and related benzophenanthridine compounds. These compounds exhibit antimicrobial, anti-inflammatory, and cytotoxic activities. The Cansema system is a topical salve that applies the extract to skin lesions, purportedly discriminating between healthy and cancerous tissue while also serving as a diagnostic aid.
Principles
- Antimicrobial activity
- Cytotoxicity against tumor cells
- NF-kappaB pathway inhibition
- Induction of apoptosis
Scientific Domains
Materials
- Sanguinarine
- Benzophenanthridine alkaloids
- Bloodroot rhizome
- Methanol (extraction solvent)
Mechanisms of Action
- Inhibition of NF-kappaB activation
- Disruption of bacterial cell membranes
- Induction of oxidative stress in neutrophils
- Apoptosis via glutathione depletion
Applications
- Topical treatment of basal cell carcinoma
- Adjunct therapy for periodontitis
- Antimicrobial agent for gastrointestinal infections
Claimed Performance
In vitro MIC values of 12.5-62.5 ug/ml against bacteria; tumor cell death observed at 2.12-4.24 uM sanguinarine; clinical studies show mixed results for periodontitis and oral leukoplakia.
Experimental Evidence
Multiple in-vitro studies (e.g., MIC, cytotoxicity assays) and limited clinical trials (double-blind studies on periodontitis, case-control study on oral leukoplakia).
Replication Status
No explicit replication reported; claims are based on literature citations.
Limitations
- Lack of robust clinical trial data
- Non-specific cytotoxicity (affects normal cells)
- Potential for scarring and residual tumor
- Regulatory warnings and FDA opposition
Red Flags
- Claims of "miraculous" cure and discrimination between healthy and cancerous tissue
- Marketing as a diagnostic tool without regulatory approval
- Historical FDA legal actions against related products
